Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1996 Sep 1;318(Pt 2):701–709. doi: 10.1042/bj3180701

Release of secretory phospholipase A2 from rat neuronal cells and its possible function in the regulation of catecholamine secretion.

A Matsuzawa 1, M Murakami 1, G Atsumi 1, K Imai 1, P Prados 1, K Inoue 1, I Kudo 1
PMCID: PMC1217675  PMID: 8809065

Abstract

Here we show that secretory phospholipase A2 (sPLA2) that is immunochemically indistinguishable from type II sPLA2 is (i) stored in neuroendocrine cells, (ii) released in response to neurotransmitters or depolarization, and (iii) involved in the regulation of catecholamine secretion by these cells. Rat brain synaptic vesicle fractions contained PLA2 activity, which was neutralized completely by an antibody raised against rat type II sPLA2. sPLA2 immunoreactive with anti-(type II sPLA2) antibody was released from synaptosomes in response to depolarization evoked by a high concentration of potassium in the presence of Ca2+. Rat pheochromocytoma PC12 cells, which differentiated into adherent cells similar to sympathetic neurons in response to nerve growth factor, were used for the detailed analysis of the dynamics and function of sPLA2 in neuronal cells. Antibody against rat type II sPLA2 precipitated approximately 80% of the PLA2 activity in PC12 cell lysates. Transcript for type II sPLA2 was detected in PC12 cells by reverse transcriptase-PCR. When neuronally differentiated PC12 cells were stimulated with carbamylcholine or potassium, sPLA2 was released into the medium and reached a maximal approximately 40% release by 15 min. Inhibitors specific to type II sPLA2 suppressed catecholamine secretion by PC12 cells which had been activated by carbamylcholine. Furthermore, treatment of PC12 cells with exogenous type II sPLA2 alone elicited catecholamine secretion. These observations indicate that sPLA2 released from neuronal cells may regulate the degranulation process leading to release of neurotransmitters and are compatible with our earlier finding that this enzyme is involved in the degranulation of rat mast cells.

Full Text

The Full Text of this article is available as a PDF (911.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ancian P., Lambeau G., Mattéi M. G., Lazdunski M. The human 180-kDa receptor for secretory phospholipases A2. Molecular cloning, identification of a secreted soluble form, expression, and chromosomal localization. J Biol Chem. 1995 Apr 14;270(15):8963–8970. doi: 10.1074/jbc.270.15.8963. [DOI] [PubMed] [Google Scholar]
  2. Barbour S. E., Dennis E. A. Antisense inhibition of group II phospholipase A2 expression blocks the production of prostaglandin E2 by P388D1 cells. J Biol Chem. 1993 Oct 15;268(29):21875–21882. [PubMed] [Google Scholar]
  3. Bradford P. G., Marinetti G. V., Abood L. G. Stimulation of phospholipase A2 and secretion of catecholamines from brain synaptosomes by potassium and A23187. J Neurochem. 1983 Dec;41(6):1684–1693. doi: 10.1111/j.1471-4159.1983.tb00881.x. [DOI] [PubMed] [Google Scholar]
  4. Channon J. Y., Leslie C. C. A calcium-dependent mechanism for associating a soluble arachidonoyl-hydrolyzing phospholipase A2 with membrane in the macrophage cell line RAW 264.7. J Biol Chem. 1990 Apr 5;265(10):5409–5413. [PubMed] [Google Scholar]
  5. Chen J., Engle S. J., Seilhamer J. J., Tischfield J. A. Cloning and characterization of novel rat and mouse low molecular weight Ca(2+)-dependent phospholipase A2s containing 16 cysteines. J Biol Chem. 1994 Sep 16;269(37):23018–23024. [PubMed] [Google Scholar]
  6. Chen J., Engle S. J., Seilhamer J. J., Tischfield J. A. Cloning and recombinant expression of a novel human low molecular weight Ca(2+)-dependent phospholipase A2. J Biol Chem. 1994 Jan 28;269(4):2365–2368. [PubMed] [Google Scholar]
  7. Clark J. D., Lin L. L., Kriz R. W., Ramesha C. S., Sultzman L. A., Lin A. Y., Milona N., Knopf J. L. A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP. Cell. 1991 Jun 14;65(6):1043–1051. doi: 10.1016/0092-8674(91)90556-e. [DOI] [PubMed] [Google Scholar]
  8. DOLE V. P., MEINERTZ H. Microdetermination of long-chain fatty acids in plasma and tissues. J Biol Chem. 1960 Sep;235:2595–2599. [PubMed] [Google Scholar]
  9. De Camilli P., Jahn R. Pathways to regulated exocytosis in neurons. Annu Rev Physiol. 1990;52:625–645. doi: 10.1146/annurev.ph.52.030190.003205. [DOI] [PubMed] [Google Scholar]
  10. Fourcade O., Simon M. F., Viodé C., Rugani N., Leballe F., Ragab A., Fournié B., Sarda L., Chap H. Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell. 1995 Mar 24;80(6):919–927. doi: 10.1016/0092-8674(95)90295-3. [DOI] [PubMed] [Google Scholar]
  11. Fujimori Y., Kudo I., Fujita K., Inoue K. Characteristics of lysophospholipase activity expressed by cytosolic phospholipase A2. Eur J Biochem. 1993 Dec 1;218(2):629–635. doi: 10.1111/j.1432-1033.1993.tb18416.x. [DOI] [PubMed] [Google Scholar]
  12. Fujimori Y., Murakami M., Kim D. K., Hara S., Takayama K., Kudo I., Inoue K. Immunochemical detection of arachidonoyl-preferential phospholipase A2. J Biochem. 1992 Jan;111(1):54–60. doi: 10.1093/oxfordjournals.jbchem.a123718. [DOI] [PubMed] [Google Scholar]
  13. Higashino K., Ishizaki J., Kishino J., Ohara O., Arita H. Structural comparison of phospholipase-A2-binding regions in phospholipase-A2 receptors from various mammals. Eur J Biochem. 1994 Oct 1;225(1):375–382. doi: 10.1111/j.1432-1033.1994.00375.x. [DOI] [PubMed] [Google Scholar]
  14. Horigome K., Hayakawa M., Inoue K., Nojima S. Purification and characterization of phospholipase A2 released from rat platelets. J Biochem. 1987 Mar;101(3):625–631. doi: 10.1093/jb/101.3.625. [DOI] [PubMed] [Google Scholar]
  15. Ishizaki J., Hanasaki K., Higashino K., Kishino J., Kikuchi N., Ohara O., Arita H. Molecular cloning of pancreatic group I phospholipase A2 receptor. J Biol Chem. 1994 Feb 25;269(8):5897–5904. [PubMed] [Google Scholar]
  16. Jahn R., Schiebler W., Ouimet C., Greengard P. A 38,000-dalton membrane protein (p38) present in synaptic vesicles. Proc Natl Acad Sci U S A. 1985 Jun;82(12):4137–4141. doi: 10.1073/pnas.82.12.4137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Karli U. O., Schäfer T., Burger M. M. Fusion of neurotransmitter vesicles with target membrane is calcium independent in a cell-free system. Proc Natl Acad Sci U S A. 1990 Aug;87(15):5912–5915. doi: 10.1073/pnas.87.15.5912. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kennedy B. P., Payette P., Mudgett J., Vadas P., Pruzanski W., Kwan M., Tang C., Rancourt D. E., Cromlish W. A. A natural disruption of the secretory group II phospholipase A2 gene in inbred mouse strains. J Biol Chem. 1995 Sep 22;270(38):22378–22385. doi: 10.1074/jbc.270.38.22378. [DOI] [PubMed] [Google Scholar]
  19. Kim D. K., Kudo I., Inoue K. Purification and characterization of rabbit platelet cytosolic phospholipase A2. Biochim Biophys Acta. 1991 Apr 24;1083(1):80–88. doi: 10.1016/0005-2760(91)90127-4. [DOI] [PubMed] [Google Scholar]
  20. Kim D. K., Rordorf G., Nemenoff R. A., Koroshetz W. J., Bonventre J. V. Glutamate stably enhances the activity of two cytosolic forms of phospholipase A2 in brain cortical cultures. Biochem J. 1995 Aug 15;310(Pt 1):83–90. doi: 10.1042/bj3100083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Knepel W., Meyen G. Effect of various blockers of arachidonic acid metabolism on release of beta-endorphin- and adrenocorticotropin-like immunoreactivity induced by phospholipase A2 from rat adenohypophysis in vitro. Neuroendocrinology. 1986;43(1):44–48. doi: 10.1159/000124507. [DOI] [PubMed] [Google Scholar]
  22. Komada M., Kudo I., Mizushima H., Kitamura N., Inoue K. Structure of cDNA coding for rat platelet phospholipase A2. J Biochem. 1989 Oct;106(4):545–547. doi: 10.1093/oxfordjournals.jbchem.a122890. [DOI] [PubMed] [Google Scholar]
  23. Kudo I., Murakami M., Hara S., Inoue K. Mammalian non-pancreatic phospholipases A2. Biochim Biophys Acta. 1993 Nov 3;1170(3):217–231. doi: 10.1016/0005-2760(93)90003-r. [DOI] [PubMed] [Google Scholar]
  24. Lambeau G., Ancian P., Barhanin J., Lazdunski M. Cloning and expression of a membrane receptor for secretory phospholipases A2. J Biol Chem. 1994 Jan 21;269(3):1575–1578. [PubMed] [Google Scholar]
  25. Lin L. L., Wartmann M., Lin A. Y., Knopf J. L., Seth A., Davis R. J. cPLA2 is phosphorylated and activated by MAP kinase. Cell. 1993 Jan 29;72(2):269–278. doi: 10.1016/0092-8674(93)90666-e. [DOI] [PubMed] [Google Scholar]
  26. MacPhee M., Chepenik K. P., Liddell R. A., Nelson K. K., Siracusa L. D., Buchberg A. M. The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia. Cell. 1995 Jun 16;81(6):957–966. doi: 10.1016/0092-8674(95)90015-2. [DOI] [PubMed] [Google Scholar]
  27. McGivney A., Morita Y., Crews F. T., Hirata F., Axelrod J., Siraganian R. P. Phospholipase activation in the IgE-mediated and Ca2+ ionophore A23187-induced release of histamine from rat basophilic leukemia cells. Arch Biochem Biophys. 1981 Dec;212(2):572–580. doi: 10.1016/0003-9861(81)90400-8. [DOI] [PubMed] [Google Scholar]
  28. Mizushima H., Kudo I., Horigome K., Murakami M., Hayakawa M., Kim D. K., Kondo E., Tomita M., Inoue K. Purification of rabbit platelet secretory phospholipase A2 and its characteristics. J Biochem. 1989 Apr;105(4):520–525. doi: 10.1093/oxfordjournals.jbchem.a122699. [DOI] [PubMed] [Google Scholar]
  29. Moskowitz N., Schook W., Puszkin S. Interaction of brain synaptic vesicles induced by endogenous Ca2+ -dependent phospholipase A2. Science. 1982 Apr 16;216(4543):305–307. doi: 10.1126/science.6278597. [DOI] [PubMed] [Google Scholar]
  30. Murakami M., Hara N., Kudo I., Inoue K. Triggering of degranulation in mast cells by exogenous type II phospholipase A2. J Immunol. 1993 Nov 15;151(10):5675–5684. [PubMed] [Google Scholar]
  31. Murakami M., Kobayashi T., Umeda M., Kudo I., Inoue K. Monoclonal antibodies against rat platelet phospholipase A2. J Biochem. 1988 Dec;104(6):884–888. doi: 10.1093/oxfordjournals.jbchem.a122577. [DOI] [PubMed] [Google Scholar]
  32. Murakami M., Kudo I., Fujimori Y., Suga H., Inoue K. Group II phospholipase A2 inhibitors suppressed lysophosphatidylserine-dependent degranulation of rat peritoneal mast cells. Biochem Biophys Res Commun. 1991 Dec 16;181(2):714–721. doi: 10.1016/0006-291x(91)91249-c. [DOI] [PubMed] [Google Scholar]
  33. Murakami M., Kudo I., Inoue K. Eicosanoid generation from antigen-primed mast cells by extracellular mammalian 14-kDa group II phospholipase A2. FEBS Lett. 1991 Dec 9;294(3):247–251. doi: 10.1016/0014-5793(91)81440-j. [DOI] [PubMed] [Google Scholar]
  34. Murakami M., Kudo I., Inoue K. Molecular nature of phospholipases A2 involved in prostaglandin I2 synthesis in human umbilical vein endothelial cells. Possible participation of cytosolic and extracellular type II phospholipases A2. J Biol Chem. 1993 Jan 15;268(2):839–844. [PubMed] [Google Scholar]
  35. Murakami M., Kudo I., Natori Y., Inoue K. Immunochemical detection of 'platelet type' phospholipase A2 in the rat. Biochim Biophys Acta. 1990 Mar 12;1043(1):34–42. doi: 10.1016/0005-2760(90)90107-9. [DOI] [PubMed] [Google Scholar]
  36. Murakami M., Kudo I., Suwa Y., Inoue K. Release of 14-kDa group-II phospholipase A2 from activated mast cells and its possible involvement in the regulation of the degranulation process. Eur J Biochem. 1992 Oct 1;209(1):257–265. doi: 10.1111/j.1432-1033.1992.tb17284.x. [DOI] [PubMed] [Google Scholar]
  37. Oka S., Arita H. Inflammatory factors stimulate expression of group II phospholipase A2 in rat cultured astrocytes. Two distinct pathways of the gene expression. J Biol Chem. 1991 May 25;266(15):9956–9960. [PubMed] [Google Scholar]
  38. Poole A. R., Howell J. I., Lucy J. A. Lysolecithin and cell fusion. Nature. 1970 Aug 22;227(5260):810–814. doi: 10.1038/227810a0. [DOI] [PubMed] [Google Scholar]
  39. Prados P., Higashidate S., Imai K. A fully automated HPLC method for the determination of catecholamines in biological samples utilizing ethylenediamine condensation and peroxyoxalate chemiluminescence detection. Biomed Chromatogr. 1994 Jan-Feb;8(1):1–8. doi: 10.1002/bmc.1130080102. [DOI] [PubMed] [Google Scholar]
  40. Shafer T. J., Atchison W. D. Transmitter, ion channel and receptor properties of pheochromocytoma (PC12) cells: a model for neurotoxicological studies. Neurotoxicology. 1991 Fall;12(3):473–492. [PubMed] [Google Scholar]
  41. Sharp J. D., White D. L., Chiou X. G., Goodson T., Gamboa G. C., McClure D., Burgett S., Hoskins J., Skatrud P. L., Sportsman J. R. Molecular cloning and expression of human Ca(2+)-sensitive cytosolic phospholipase A2. J Biol Chem. 1991 Aug 15;266(23):14850–14853. [PubMed] [Google Scholar]
  42. Suga H., Murakami M., Kudo I., Inoue K. Participation in cellular prostaglandin synthesis of type-II phospholipase A2 secreted and anchored on cell-surface heparan sulfate proteoglycan. Eur J Biochem. 1993 Dec 15;218(3):807–813. doi: 10.1111/j.1432-1033.1993.tb18435.x. [DOI] [PubMed] [Google Scholar]
  43. Tanaka K., Kato T., Matsumoto K., Yoshida T. Antiinflammatory action of thielocin A1 beta, a group II phospholipase A2 specific inhibitor, in rat carrageenan-induced pleurisy. Inflammation. 1993 Apr;17(2):107–119. doi: 10.1007/BF00916098. [DOI] [PubMed] [Google Scholar]
  44. Tanaka K., Matsutani S., Matsumoto K., Yoshida T. A novel type of phospholipase A2 inhibitor, thielocin A1 beta, and mechanism of action. J Antibiot (Tokyo) 1992 Jul;45(7):1071–1078. doi: 10.7164/antibiotics.45.1071. [DOI] [PubMed] [Google Scholar]
  45. Tanaka K., Matsutani S., Matsumoto K., Yoshida T. Effect of thielocin A1 beta on bee venom phospholipase A2-induced edema in mouse paw. Eur J Pharmacol. 1995 Jun 12;279(2-3):143–148. doi: 10.1016/0014-2999(95)00148-e. [DOI] [PubMed] [Google Scholar]
  46. Tzeng M. C., Yen C. H., Hseu M. J., Dupureur C. M., Tsai M. D. Conversion of bovine pancreatic phospholipase A2 at a single site into a competitor of neurotoxic phospholipases A2 by site-directed mutagenesis. J Biol Chem. 1995 Feb 3;270(5):2120–2123. doi: 10.1074/jbc.270.5.2120. [DOI] [PubMed] [Google Scholar]
  47. Ueda T., Greengard P., Berzins K., Cohen R. S., Blomberg F., Grab D. J., Siekevitz P. Subcellular distribution in cerebral cortex of two proteins phosphorylated by a cAMP-dependent protein kinase. J Cell Biol. 1979 Nov;83(2 Pt 1):308–319. doi: 10.1083/jcb.83.2.308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Wang J. P., Teng C. M. Comparison of the enzymatic and edema-producing activities of two venom phospholipase A2 enzymes. Eur J Pharmacol. 1990 Nov 13;190(3):347–354. doi: 10.1016/0014-2999(90)94199-8. [DOI] [PubMed] [Google Scholar]
  49. Yen C. H., Tzeng M. C. Identification of a new binding protein for crotoxin and other neurotoxic phospholipase A2s on brain synaptic membranes. Biochemistry. 1991 Dec 3;30(48):11473–11477. doi: 10.1021/bi00112a015. [DOI] [PubMed] [Google Scholar]
  50. Yoshida T., Nakamoto S., Sakazaki R., Matsumoto K., Terui Y., Sato T., Arita H., Matsutani S., Inoue K., Kudo I. Thielocins A1 alpha and A1 beta, novel phospholipase A2 inhibitors from ascomycetes. J Antibiot (Tokyo) 1991 Dec;44(12):1467–1470. doi: 10.7164/antibiotics.44.1467. [DOI] [PubMed] [Google Scholar]
  51. Yoshihara Y., Watanabe Y. Translocation of phospholipase A2 from cytosol to membranes in rat brain induced by calcium ions. Biochem Biophys Res Commun. 1990 Jul 31;170(2):484–490. doi: 10.1016/0006-291x(90)92117-i. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES